Alzira Alves de Siqueira Carvalho

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score

I Dajti, José Ignacio Valenzuela, L Boccalatte et al. · British journal of surgery · 2021 · 47 citations · Full text

Computing, Perioperative Medicine, Surgery +17

Prevalence of presenile dementia in a tertiary outpatient clinic

Satomi Fujihara, Sônia Maria Dozzi Brucki, Maria Sheila Guimarães Rocha et al. · Arquivos de Neuro-Psiquiatria · 2004 · 46 citations · Full text

Medicine, Geriatric Medicine, Neurology +12